4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-05-29NCT07615751
Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast CancerAdvanced Breast CancerNot yet recruitingPhase 22025-06-27NCT07041437
Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain MetastasisBreast Cancer Brain Metastases; Breast Cancer MetastaticRecruitingPhase 1 / Phase 22025-02-06NCT06718933
Study of HRS-2189 Combined HRS-5041 in Prostate CancerProstate Cancer Metastatic DiseaseNot yet recruitingPhase 22024-12-18NCT06738745